Grufity logoGrufity logo

Insulet Corp Stock Research

PODD

315.16USD-10.87(-3.33%)Market Closed

Market Summary

USD315.16-10.87
Market Closed
-3.33%

PODD Alerts

PODD Stock Price

PODD RSI Chart

PODD Valuation

Market Cap

21.7B

Price/Earnings (Trailing)

4.7K

Price/Sales (Trailing)

16.63

EV/EBITDA

484.44

Price/Free Cashflow

-5.6K

PODD Price/Sales (Trailing)

PODD Profitability

EBT Margin

0.75%

Return on Equity

0.97%

Return on Assets

0.2%

Free Cashflow Yield

-0.02%

PODD Fundamentals

PODD Revenue

Revenue (TTM)

1.3B

Revenue Y/Y

20.15%

Revenue Q/Q

8.48%

PODD Earnings

Earnings (TTM)

4.6M

Earnings Y/Y

-41.78%

Earnings Q/Q

426.92%

Price Action

52 Week Range

181.00326.74
(Low)(High)

Last 7 days

7.6%

Last 30 days

3.1%

Last 90 days

2.9%

Trailing 12 Months

42.5%

PODD Financial Health

Current Ratio

3.6

Debt/Equity

2.95

Debt/Cashflow

0.08

PODD Investor Care

Shares Dilution (1Y)

0.48%

Diluted EPS (TTM)

0.07

Peers (Alternatives to Insulet)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
104.1B
18.4B
2.26% 8.00%
44.16
5.64
7.84% 18.25%
84.2B
6.2B
-4.47% -13.27%
63.66
13.53
8.97% -22.43%
69.1B
12.7B
0.59% 12.45%
99.06
5.45
6.68% -32.95%
67.4B
19.0B
-5.16% -6.78%
41.86
3.55
-0.43% -8.78%
49.8B
5.4B
2.41% -25.12%
32.74
9.26
2.86% 1.25%
MID-CAP
7.2T
489.7M
9.34% 31.15%
82.2K
16.8K
106.51% 2464.23%
10.2B
847.1M
-3.64% 34.52%
-5.1K
12.05
13.32% -137.89%
5.2B
1.0B
-11.64% -20.31%
30.19
5.09
6.76% 24.45%
3.5B
410.9M
4.51% -3.13%
-29.82
8.43
27.29% -14.60%
2.7B
801.2M
1.13% -58.87%
-28.25
3.34
14.00% -707.69%
SMALL-CAP
1.7B
138.6M
-15.68% 29.18%
-30.43
12.07
36.62% -10.44%
1.6B
350.9M
10.38% 49.06%
-10.84
4.7
44.26% -5.42%
1.3B
820.0M
-8.35% -12.22%
25.89
1.59
10.13% 701.59%
828.4M
239.8M
0.30% 1.49%
-21.88
3.45
-4.74% -31.15%

Financials for Insulet

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue5.0%1,3051,2431,1781,1421,099
Gross Profit0.5%806802802794752
  S&GA Expenses4.0%588565542484466
  R&D Expenses4.5%180173165163160
EBITDA5.9%46.0044.0054.0053.00-
EBITDA Margin0.9%0.04*0.04*0.05*0.05*-
Earnings Before Taxes-53.1%10.0021.0042.0050.0021.00
EBT Margin-55.3%0.01*0.02*0.04*0.04*-
Interest Expenses31.7%-26.70-39.10-48.60-56.70-61.20
Net Income-72.6%5.0017.0035.0045.0017.00
Net Income Margin-73.9%0.00*0.01*0.03*0.04*-
Free Cahsflow91.8%-3.90-47.50-126-138-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets3.9%2,2512,1662,1142,0692,049
  Current Assets-1.1%1,3141,3291,3091,2851,330
    Cash Equivalents-6.4%690737724725806
  Inventory5.9%347328320315303
  Net PPE8.5%600553536538537
  Goodwill0.2%52.0052.0052.0052.0040.00
Liabilities2.1%1,7751,7381,6911,6231,493
  Current Liabilities9.1%365334279215229
  Long Term Debt-0.3%1,4071,4121,4161,274-
    LT Debt, Current2.2%28.0027.0026.0026.0025.00
    LT Debt, Non Current-0.4%1,3741,3801,3851,3911,249
Shareholder's Equity11.3%476428422447556
  Retained Earnings2.8%-584-601-596-561-649
  Additional Paid-In Capital1.8%1,0411,0221,0119961,208
Accumulated Depreciation-179----
Shares Outstanding0.1%70.0069.0069.0069.0069.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations178.0%11943.00-39.70-46.70-68.10
  Share Based Compensation6.8%41.0038.0038.0035.0034.00
Cashflow From Investing-37.4%-191-139-117-106-82.70
Cashflow From Financing-47.6%-40.30-27.3019.0049.0041.00

Risks for PODD

What is the probability of a big loss on PODD?

76.2%


Probability that Insulet stock will be more than 20% underwater in next one year

45%


Probability that Insulet stock will be more than 30% underwater in next one year.

0%


Probability that Insulet stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PODD drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Insulet was unfortunately bought at previous high price.

Drawdowns

Returns for PODD

Cumulative Returns on PODD

29.1%


10-Year Cumulative Returns

38.9%


7-Year Cumulative Returns

29.3%


5-Year Cumulative Returns

23.1%


3-Year Cumulative Returns

What are the long-term rolling returns for PODD?

FIve years rolling returns for Insulet.

Annualized Returns

Which funds bought or sold PODD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
new
-
296,745
296,745
0.01%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-40.12
-7,444,670
24,704,300
0.03%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-90.91
-27,161,000
3,588,000
0.02%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
294,390
294,390
-%
2023-03-01
Regal Investment Advisors LLC
new
-
202,246
202,246
0.02%
2023-02-28
Voya Investment Management LLC
reduced
-0.01
1,854,300
8,401,300
0.01%
2023-02-24
National Pension Service
reduced
-4.96
4,989,980
28,728,900
0.06%
2023-02-24
SRS Capital Advisors, Inc.
added
133
1,061
2,061
-%
2023-02-24
NATIXIS
sold off
-100
-2,388,000
-
-%
2023-02-23
Portman Square Capital LLP
new
-
22,051,000
22,051,000
1.63%

1–10 of 44

Latest Funds Activity

Are funds buying PODD calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own PODD
No. of Funds

Insulet News

Seeking Alpha

Tracking Ole Andreas Halvorsen's Viking Global Portfolio – Q4 2022 ....

Seeking Alpha,
11 minutes ago

Nasdaq

Yahoo Finance

Investor's Business Daily

Investor's Business Daily

Zacks Investment Research

Company News for Mar 14, 2023.

Zacks Investment Research,
8 days ago

Investor's Business Daily

Schedule 13G FIlings of Insulet

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
capital world investors
5.9%
4,097,334
SC 13G/A
Feb 13, 2023
capital research global investors
8.9%
6,151,361
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
9.40%
6,528,255
SC 13G/A
Feb 06, 2023
wellington management group llp
8.21%
5,702,028
SC 13G
Jan 31, 2023
blackrock inc.
7.6%
5,244,355
SC 13G/A
Feb 11, 2022
capital research global investors
11.3%
7,811,512
SC 13G/A
Feb 11, 2022
capital world investors
9.8%
6,762,544
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 03, 2022
blackrock inc.
6.8%
4,655,627
SC 13G/A

PODD Fair Value

Insulet fair value in different scenarios

The table shows the Fair Value estimates for Insulet for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

5.58

-98.23%

8.43

-97.33%

15.88

-94.96%

26.71

-91.52%

38.19

-87.88%
Current Inflation

5.15

-98.37%

7.61

-97.59%

14.01

-95.55%

23.21

-92.64%

33.00

-89.53%
Very High Inflation

4.61

-98.54%

6.63

-97.90%

11.82

-96.25%

19.16

-93.92%

27.03

-91.42%

Historical Insulet Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Insulet

View All Filings
Date Filed Form Type Document
Mar 16, 2023
4
Insider Trading
Mar 15, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 13, 2023
4
Insider Trading
Mar 10, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading

Latest Insider Trading transactions for PODD

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-14
Alpuche Charles
sold (taxes)
-399,604
309
-1,293
advisor
2023-03-14
Alpuche Charles
acquired
399,955
31.5846
12,663
advisor
2023-03-13
Alpuche Charles
sold
-7,140,820
305
-23,401
advisor
2023-03-13
Alpuche Charles
acquired
730,345
31.21
23,401
advisor
2023-03-09
Alpuche Charles
acquired
124,840
31.21
4,000
advisor
2023-03-09
Spears Michael P
acquired
99,532
74.5
1,336
advisor
2023-03-09
Spears Michael P
sold (taxes)
-99,194
287
-345
advisor
2023-03-09
Alpuche Charles
sold
-1,163,600
290
-4,000
advisor
2023-03-01
Petrovic Shacey
sold
-4,149,450
276
-15,000
advisor
2023-02-28
Benjamin Eric
sold (taxes)
-40,901
276
-148
evp, innovation and strategy

1–10 of 50

About Insulet

PODD Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Revenue$ 1,055.4$ 1,040.6$ 904.4
Revenue from related party249.958.20.0
Total revenue1,305.31,098.8904.4
Cost of revenue499.7346.7322.1
Gross profit805.6752.1582.3
Research and development expenses180.2160.1146.8
Selling, general and administrative expenses587.8466.0384.0
Operating income37.6126.051.5
Interest expense, net(26.7)(61.2)(45.1)
Loss on extinguishment of debt0.0(42.4)0.0
Other (expense) income, net(1.1)(1.9)3.3
Income before income taxes9.820.59.7
Income tax expense(5.2)(3.7)(2.9)
Net income$ 4.6$ 16.8$ 6.8
Net income per share:   
Basic (in dollars per share)$ 0.07$ 0.25$ 0.11
Diluted (in dollars per share)$ 0.07$ 0.24$ 0.10
Weighted-average number of common shares outstanding (in thousands):   
Basic (in shares)69,37567,69864,735
Diluted (in shares)69,91068,57965,946

PODD Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Thousands, $ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current Assets  
Cash and cash equivalents$ 674.7$ 791.6
Accounts receivable trade, net140.9135.2
Accounts receivable trade, net — related party64.725.8
Inventories346.8303.2
Prepaid expenses and other current assets86.974.0
Total current assets1,314.01,329.8
Property, plant and equipment, net599.9536.5
Other intangible assets, net75.536.6
Goodwill51.739.8
Other assets210.0106.1
Total assets2,251.12,048.8
Current Liabilities  
Accounts payable30.837.7
Accrued expenses and other current liabilities301.0164.3
Accrued expenses and other current liabilities — related party5.41.7
Current portion of long-term debt27.525.1
Total current liabilities364.7228.8
Long-term debt, net1,374.31,248.8
Other liabilities35.714.9
Total liabilities1,774.71,492.5
Commitments and contingencies (Note 17)
Stockholders’ Equity  
Preferred stock, $.001 par value, 5,000,000 shares authorized; none issued and outstanding0.00.0
Common stock, $.001 par value, 100,000,000 authorized; 69,511,286 and 69,178,691 issued and outstanding0.10.1
Additional paid-in capital1,040.61,207.9
Accumulated deficit(584.3)(649.5)
Accumulated other comprehensive income (loss)20.0(2.2)
Total stockholders’ equity476.4556.3
Total liabilities and stockholders’ equity$ 2,251.1$ 2,048.8
Preferred stock, outstanding (in shares)00
Preferred stock, issued (in shares)00